Tonix Clinical Site
Welcome,         Profile    Billing    Logout  
 0 Trials 
12 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Mezhebovsky, Irina
ADHD, NCT06215144: Study to Evaluate NRCT-101SR in Pediatric Subjects With

Recruiting
2/3
160
US
NRCT-101SR, Matching Placebo
Neurocentria, Inc.
Attention-Deficit/Hyperactivity Disorder (ADHD)
12/24
02/25
PREVAIL, NCT05472090: A Phase 2 Study to Evaluate the Efficacy and Safety of TNX-102 SL in Patients With Multi-Site Pain Associated With Post-Acute Sequelae of SARS-CoV-2 Infection

Completed
2
63
US
TNX-102 SL, Placebo SL Tablet
Tonix Pharmaceuticals, Inc.
Post-Acute Sequelae of SARS-CoV-2 (PASC) Infection, COVID-19, Long COVID, Long Haul COVID
07/23
07/23
NCT06673368: A Phase 2 Randomized Double-Blind, Parallel, Adaptive-Design, Clinical Trial to Evaluate the Safety and Efficacy of NRCT-101SR with NRCT-202XR Compared to NRCT-202XR Alone in Subjects with Attention-Deficit/Hyperactivity Disorder

Recruiting
2
60
US
NRCT-101SR, NRCT-202XR
Neurocentria, Inc.
ADHD
11/25
11/25
Monaghan, Joanne
NCT05518123 / 2022-001176-34: Efficacy and Tolerability of Rimegepant for the Prevention of Migraine in Adults With History of Inadequate Response to Oral Preventive Medications

Recruiting
4
600
Europe, Canada, US, RoW
Rimegepant, Placebo
Pfizer, Pfizer
Migraine
02/25
08/25
NCT05509400 / 2022-001175-14: Efficacy and Tolerability of Rimegepant for the Acute Treatment of Migraine in Adults Unsuitable for Triptan Use

Recruiting
4
600
Europe, Canada, US, RoW
Rimegepant, Placebo
Pfizer, Pfizer
Migraine
05/25
08/25
ADHD, NCT06215144: Study to Evaluate NRCT-101SR in Pediatric Subjects With

Recruiting
2/3
160
US
NRCT-101SR, Matching Placebo
Neurocentria, Inc.
Attention-Deficit/Hyperactivity Disorder (ADHD)
12/24
02/25
RISE 3, NCT06309966: Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy

Recruiting
2/3
390
Europe, US, RoW
BHV-7000, Placebo
Biohaven Therapeutics Ltd.
Focal Epilepsy
08/25
09/25
SHINE, NCT06425159: A Study to Determine if BHV-7000 is Effective and Safe in Adults With Idiopathic Generalized Epilepsy With Generalized Tonic-clonic Seizures

Recruiting
2/3
242
Europe, US, RoW
BHV-7000, Placebo
Biohaven Therapeutics Ltd.
Generalized Epilepsy
07/26
07/27
PREVAIL, NCT05472090: A Phase 2 Study to Evaluate the Efficacy and Safety of TNX-102 SL in Patients With Multi-Site Pain Associated With Post-Acute Sequelae of SARS-CoV-2 Infection

Completed
2
63
US
TNX-102 SL, Placebo SL Tablet
Tonix Pharmaceuticals, Inc.
Post-Acute Sequelae of SARS-CoV-2 (PASC) Infection, COVID-19, Long COVID, Long Haul COVID
07/23
07/23
NCT06419608: Efficacy and Safety Study of BHV-7000 Monotherapy in Major Depression

Recruiting
2
300
US
BHV-7000, Placebo
Biohaven Therapeutics Ltd.
Major Depressive Disorder
05/25
07/25
NCT06673368: A Phase 2 Randomized Double-Blind, Parallel, Adaptive-Design, Clinical Trial to Evaluate the Safety and Efficacy of NRCT-101SR with NRCT-202XR Compared to NRCT-202XR Alone in Subjects with Attention-Deficit/Hyperactivity Disorder

Recruiting
2
60
US
NRCT-101SR, NRCT-202XR
Neurocentria, Inc.
ADHD
11/25
11/25
Hope, NCT05637801: A Pivotal Study of Sensory Stimulation in Alzheimer's Disease ( Study, CA-0011)

Recruiting
N/A
600
US
Sensory Stimulation System (GS120) - Active, Sensory Stimulation System (GS120) - Sham
Cognito Therapeutics, Inc.
Alzheimer Disease, Alzheimer Disease 1, Alzheimer Disease 2, Alzheimer Disease 3, Alzheimer Disease, Early Onset, Alzheimer Disease, Late Onset, Alzheimer Disease 9, Alzheimer Disease 4, Alzheimer Disease 7, Alzheimer Disease 17, Alzheimer's Dementia Late Onset, Alzheimer Disease 5, Alzheimer Disease 6, Alzheimer Disease 8, Alzheimer Disease 10, Alzheimer Disease 11, Alzheimer Disease 12, Alzheimer Disease 13, Alzheimer Disease 14, Alzheimer Disease 15, Alzheimer Disease 16, Alzheimer Disease 18, Alzheimer Disease 19, Dementia, Dementia Alzheimers, Dementia, Mild, Dementia of Alzheimer Type, Dementia Moderate, Dementia Senile, Mild Cognitive Impairment, Mild Dementia, MCI, Cognitive Impairment, Cognitive Decline, Cognitive Impairment, Mild
11/25
12/25

Download Options